Review Clinical studies Clinical studies on GLP-1 agonists and multiple sclerosis investigations have utilized various research methods and models
The gastrointestinal adverse effects are attributed to the GLP-1 activity these medications produce and there are no therapeutic measures for improving said symptomatology.42,7173 Therefore, the best measure to consider in this group of patients is to use the drug that has less association with gastrointestinal adverse effects
KG suppresses DNA damage through carnitine The cells used for most of these studies (FT282 and Ovcar8) have wild-type BRCA1 or BRCA2 and are HR proficient
To further highlight the importance of eating a variety of foods, Vitamin B12 and B9, folate, are codependent on each other to function properly in the body
This supports topical efficacy on dermal structures, including fibroblasts
Financial support None declared